TRX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Not a good buy right now for an impatient investor. TRX just printed an extreme -25.23% regular-session drop followed by a small post-market bounce (+4.29% to 1.70), which signals instability rather than a clean, high-confidence entry. The chart trend is still structurally bullish (SMA_5 > SMA_20 > SMA_200), but momentum is no longer accelerating (MACD histogram positive but contracting) and price is sitting right around the pivot (1.695), meaning it can easily fail and retest lower support.
Intellectia Proprietary Trading Signals
With no proprietary “strong buy” trigger today and Wall Street price targets mostly below the current price area, the risk/reward is not attractive enough to call this a buy now.
Trend/structure: Bullish moving-average stack (SMA_5 > SMA_20 > SMA_200) indicates the broader trend is up. Momentum: MACD histogram is above zero (0.0963) but positively contracting, suggesting the up-move is losing momentum. RSI(6) ~57.7 is neutral (not oversold), so the stock is not presenting a classic “washed-out” technical buy.
Price action context: A -25% regular-session move is a technical red flag (often tied to a catalyst, liquidity, or positioning), and the modest post-market rebound does not yet confirm a reversal.
Key levels: Pivot ~1.695 (current area), near-term resistance R1 ~2.415, supports S1 ~0.976 then S2 ~0.531. A convincing reclaim and hold above the pivot is needed for a cleaner long setup; otherwise downside to S1 is plausible in this volatility regime.
TRX reported a significant increase in profitability tied to higher gold prices and plans to fund a $30M plant expansion via internal cash flow (a constructive operational/capital funding signal).
are generally below the current ~$1.63–$1.70 area, implying limited upside per those models unless targets are updated again.
Latest quarter: 2026/Q1. Revenue rose to ~$25.12M (+100.49% YoY) and gross margin expanded to 56.54% (+46.97% YoY), showing strong top-line growth and improved unit economics. However, net income fell to -$4.168M (more negative YoY per provided data) and EPS remains negative (-$0.01). Overall: operating metrics look better, but profitability is not yet consistently translating to bottom-line earnings in the snapshot.
Recent trend: analysts have been consistently positive with repeated Buy reiterations and incremental price-target hikes (H.C. Wainwright: $1.10 → $1.20 → $1.40 → $1.50; Roth: $0.85 → $1.25). Pros: bullish outlook tied to higher gold prices, record operational metrics, and growth funded by internal cash flow. Cons: the current trading price (~1.63–1.70) is already above most disclosed targets ($1.20–$1.50), so Wall Street’s published upside looks capped unless targets move higher again.
